Overall, these findings demonstrate that PhIP is an important risk factor for bone metastasis in RCC and may enhance osteoclastic bone resorption, suggesting that 6-SG could exhibit antimetastatic activity by blocking PhIP-induced bone resorption in an in vitro RCC model [77]. This evidence concerns the gene PHIP and renal cell carcinoma.